CAS: 56187-47-4; (6R,7R)-7-(2-(3,5-Dichloro-4-Oxopyridin-1(4H)-yl)Acetamido)-3-(((5-Methyl-1,3,4-Thiadiazol-2-yl)Thio)Methyl)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid

该化合物是一种广泛频谱的甲状腺素抗生素,被归类为乙状乳腺抗生素,主要用于通过抑制细菌细胞壁合成治疗各种细菌感染,最终导致细胞分解和死亡;Cefazedone展示了针对各种抗原细菌的广泛活动,使其有效治疗各种病原体造成的感染;该化合物的特点是其稳定性,它针对某些乙状腺素,即某些细菌为抗抗生素而生成的酶.Cefazedone通常通过注射进行治疗,并因其毒性特征相对较低而闻名.然而,它与其他抗过敏反应,胃肠扰动和正常植物改变等副作用一样,它也可能产生副作用,例如过敏反应,胃肠扰动和正常植物改变.它的致癌性包括吸收,分布,代谢和排泄,这对确定剂量疗法至关重要.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

2-(3,5-dichloro-4-oxopyridine-1(4H)-yl)acetic acid (6R,7R)-7-amino-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]°Ct-2-ene-2-carboxylic acid 3-deacetyloxy-7-amin°Cephalosporanic acid 2-mercapto-5-methyl-1,3,4-thiadiazole(6R,7R)-3-[[(5-methyl-1,3,4-thiadiazolyl-2-yl)thio]methyl]-7-[2-(3,5-dichloro-4-pyridone-1-acetylamido)]-8-oxo-5-thia-1-azabicyclo[4.2.0]°Ct-2-ene-2-carboxylic acid sodium salt

合成工艺路线路线简述

    7-氨基头孢烷酸置于三氟化硼乙醚,溶剂黄146,三乙胺体系中,用 乙腈 作为反应溶剂,化学反应 0.5H,反应生成 头孢西酮
    参考文献:一种头孢西酮的合成工艺
    标题:一种头孢西酮的合成工艺
    摘要:本发明公开了一种头孢西酮的合成工艺,本发明将化合物ⅱ与7‑aca反应制备化合物ⅲ,化合物ⅲ与化合物ⅳ反应制得终产品头孢西酮(ⅰ).本发明合成路线简单,反应条件温和,缩短了反应周期,降低了生产成本低,提高了产品总收率及纯度,适合工业化生产.

    海关参考信息

    专利信息


    专利号:US-5945414-A
    优先权日:1996-12-03
    标 题:Process for the preparation of new intermediates useful in the synthesis of cephalosporins
    发明人:SOGLI LORIS; TERRASSAN DANIELE; BERNASCONI ERMANNO; SALTO FRANCISCO
    权利人:ANTIBIOTICOS SPA
    摘要:Cefazolin, cefazedone, cefoperazone, cefamandole, cefatrizine or ceftriaxone is prepared by reacting glutaryl 7-ACA of the formula: with a compound of formula (II): R-SH(II) wherein R is 5-methyl-1,3,4-thiadiazol-2-yl, 1H-1,2,3-triazol-4-yl, 1-methyl-tetrazol-5-yl or 1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl group, and R1 and R2 are both hydrogen and the other is an acyl group, in an aqueous solution in an amount of 3-5 mols per mol of glutaryl 7-ACA to about 90 DEG C. and for a time from about 2 to about 10 hours; optionally recovering the excess of the compound of formula (II), thereby preparing a compound of formula (III) in an aqueous solution: wherein R is as above defined and optionally deacylating said compound of formula (III); and converting the resulting compound of formula (I) wherein R, R1 and R2 are as defined above in the presence of a non-chlorinated solvent into one of said cephalosporins.

    专利号:US-8017776-B2
    优先权日:2003-07-15
    标题 :Methods for synthesis of acyloxyalkyl compounds
    发明人:BHAT LAXMINARAYAN; GALLOP MARK A
    权利人:XENOPORT INC
    摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

    专利号:US-8143437-B2
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
    发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
    权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
    摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

    专利号:US-5387679-A
    优先权日:1991-07-15
    标题 :Process for the preparation of cephalosporins intermediates
    发明人:SOGLI LORIS; TERRASSAN DANIELE; RIBALDONE GIUSEPPE
    权利人:ANTIBIOTICOS SPA
    摘要:PCT No. PCT/EP92/01595 Sec. 371 Date Mar. 15, 1993 Sec. 102(e) Date Mar. 15, 1993 PCT Filed Jul. 14, 1992 PCT Pub. No. WO93/02085 PCT Pub. Date Feb. 4, 1993.The present invention relates to a process for preparing a compound of formula (I) ntains at least one nitrogen atom with or without oxygen or sulphur and R1 and R2 are both hydrogen atoms or one of them is an hydrogen atom and the other is an acyl group; the process comprising reacting a compound of formula (II) (II) wherein R1 and R2 are each as defined above, and wherein, if necessary, any reactive group is protected by a suitable protective group, or a salt thereof, with a compound of formula (III) R-SH(III) wherein R is as defined above, or a salt thereof, in the presence of an acid and of a compound of formula (IV) (IV) wherein each of R3 and R4 is a C1-C4 alkyl group or R3 and R4 taken together are a C2 or C3 alkylene chain and, if necessary, removing the protective groups possibly present. The compounds of formula (I) are useful intermediates in the synthesis of Cefazolin and Cefazedone.

    专利号:WO-0032619-A1
    优先权日:1998-11-30
    标题:Methods and compositions for identification of inhibitors of ribosome assembly
    发明人:DAMMEL CAROL S; WATSON JULIE C
    权利人:RIBOGENE INC
    摘要:The invention provides a means for identifying novel antibiotics by screening for compounds that inhibit bacterial ribosome assembly and ribosomal protein synthesis, which comprises the screening of test compounds to identify those that inhibit the activity of a bacterial ribosomal protein. The in vitro and in vivo assays detect (a) increased translation of a reporter mRNA that is normally repressed in the presence of a ribosomal protein, (b) increased growth in cells that over-express ribosomal protein, and (c) decreased binding of the ribosomal protein to its target RNA. The invention encompasses the (a) methods of screening and testing compounds by the above methods, (b) compounds that are identified in the assay which inhibit ribosome assembly and protein synthesis and (c) methods for treatment using said compounds.

    专利号:US-2025002508-A1
    优先权日:2020-05-05
    标题 :Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof
    发明人:HECKER SCOTT J; BOYER SERGE HENRI; BIO MATTHEW M; FANG YUANQING; GONZALES DE CASTRO ANGELA; LEFORT LAURENT; ZHU ZUOLIN; LINDER THOMAS
    权利人:QPEX BIOPHARMA INC
    摘要:Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).
    常州湖滨医药原料有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hubinchem.com
    企业联系电话:0519-85223897👤
    📞常州湖滨医药原料有限公司 ⚠️参考联系方式
    联系人:陈飞
    电话:0519-85223897
    手机:15861132333;13766960291
    传真:0519-85223902
    邮箱:manager@czredsunpharm.com
    通信地址: 江苏省常州市武进区
    邮编: 213100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市武进区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    金隆制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemill.com
    电话: 00852-21919580👤
    📞金隆制药有限公司 ⚠️参考联系方式

    销售电话:00852-21919580
    邮箱:chemille@netvigator.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    山东天铭医药集团有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sdpysh.com
    电话: 0531-89702887/0531-88993893👤
    📞山东天铭医药集团有限公司 ⚠️参考联系方式

    销售电话:0531-89702887/0531-88993893
    邮箱:sales@sdsihuanpharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    山东四环药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sdsihuanpharm.com
    企业联系电话:0531-89702887-👤
    📞山东四环药业股份有限公司 ⚠️参考联系方式
    联系人:李经理
    电话:0531-89702887-
    手机:13256103272
    传真:0531-89702886
    邮箱:sales@sdsihuanpharm.com
    通信地址: 山东四环药业股份有限公司
    邮编: 253100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东四环药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Wu D, Qian ZY, Guo T, Tang W, Xiang Y, Zheng H. Determination of cefazedone in human plasma by high performance liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study on Chinese volunteers. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2911-5. doi: 10.1016/j.jchromb.2010.08.008. Epub 2010 Aug 17. 128(9):1160-4. doi: 10.4103/0366-6999.156086.
    3: Adam D, Hofstetter AG, Reichart B, Schneider C, Wolff H, Koch E. Zur Diffusion von Cefazedon in das Herzmuskel-, Prostata- und Hautgewebe sowie in die Gallenflüssigkeit [The diffusion of cefazedone into heart muscle, prostatic and skin tissue and into bile]. Arzneimittelforschung. 1979;29(12):1901-6. German. 90(1):135-42. doi: 10.1016/0041-008x(87)90314-0. 973C:97-103. doi: 10.1016/j.jchromb.2014.10.018. Epub 2014 Oct 23. 29(2a):449-52. 29(2a):412-4. 29(2a):437-43. 29(2a):381-4. 122(12):431-4. German. 6(2):288-91. doi: 10.1093/jac/6.2.288. 97(5):214-8. German. 29(2a):456-60. 29(2a):461-2. 29(2a):369-78. 29(2a):400-3. 29(2a):435-6. 29(2a):384-7. 29(2a):453-6. 28(2):71-8. doi: 10.1002/ajh.2830280202. Erratum in: Am J Hematol 1988 Dec;29(4):241.

    合成参考文献


    摘要:Hitzenberger G, Jaschek I. [Pharmacokinetics and tolerance of Cefazedone compared with Cefazoline (author's transl)]. Wien Med Wochenschr. 1980 Feb 15;130(3):135–42.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知